Results

eNauka >  Results >  Lazertinib Versus Gefitinib as First-Line Treatment in Patients With EGFR-Mutated Advanced Non–Small-Cell Lung Cancer: Results From LASER301
Title: Lazertinib Versus Gefitinib as First-Line Treatment in Patients With EGFR-Mutated Advanced Non–Small-Cell Lung Cancer: Results From LASER301
Authors: Cho, Byoung Chul; Ahn, Myung-Ju; Kang, Jin Hyoung; Soo, Ross A.; Reungwetwattana, Thanyanan; Yang, James Chih-Hsin; Cicin, Irfan; Kim, Dong-Wan; Wu, Yi-Long; Lu, Shun;
Lee, Ki Hyeong; Pang, Yong-Kek; Zimina, Anastasia; Fong, Chin Heng; Poddubskaya, Elena; Sezer, Ahmet; How, Soon Hin; Danchaivijitr, Pongwut; Kim, YuKyung; Lim, Yeji; An, Taewon; Lee, Hana; Byun, Hae Mi; Zaric, Bojan  ;
Issue Date: 2023
Publication: Journal of Clinical Oncology
ISSN: 0732-183X Journal of Clinical Oncology Search Idenfier
Type: Article
Collation: vol. 41 br. 26 str. 4208-4217
DOI: 10.1200/JCO.23.00515
WoS-ID: 001069556400005
Scopus-ID: 2-s2.0-85170112349
PMID: 37379502
URI: https://enauka.gov.rs/handle/123456789/933671
Project: The authors would like to thank all the patients who participated in this study and their families and caregivers. The authors would also like to thank the physicians and nurses who cared for the patients and the staff at the clinical sites.
Metadata source: (Preuzeto iz CrossRef-a) Zarić, Bojan
(Preuzeto iz Nasi u WoS)
M-category: 
21a+M21a+

129
SCOPUSTM
60
PubMed CentralTM
6
OpenCitations
126
WEB OF SCIENCETM
Altmetric
Dimensions
Unpaywall

Items in eNauka are protected by copyright, with all rights reserved, unless otherwise indicated.